Mark Your Calendar for BPI Europe 2023!
8-11 May 2023RAI in AmsterdamKey Sessions
Nicole Borth
KEYNOTE: How to Train Your Cell
BOKU University and Austrian Center of Industrial Biotechnology
Christoph Herwig, PhD
Lifecycling of Hybrid Digital Twins: Strategies to Generate, Adapt and Deploy Digital Twins
Vienna University of Technology, Austria & Senior Scientific Advisor, Körber AG, Austria
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
May 17 - CET/CEST (Cent Europe Summer, GMT+2)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
May 17 - CET/CEST (Cent Europe Summer, GMT+2)
search
Streams
Clear
08:20 - 08:3010 mins
Cell & Gene Therapy - Lehar 4
Chairperson’s Opening Remarks
- Volker Huppert - Chief Development Officer, Glycostem Therapeutics
08:30 - 09:0030 mins
Cell & Gene Therapy - Lehar 4
CGT Process Development - Challenges and Avenues
- Hemant Dhamne, Remote - Head, Process Development, Gene Therapy Vector Facility, King's College London, UK
09:00 - 09:3030 mins
Cell & Gene Therapy - Lehar 4
Development of Viral Vectors for Gene Therapy
- Catarina Vieira - Principal Scientist, Oxford Biomedica
09:30 - 10:0030 mins
Cell & Gene Therapy - Lehar 4
Use of a Novel Cell Lysis Buffer for Protection of AAVs and Enhancing Manufacturing Efficiency
- Nandu Deorkar, PhD - Vice President, Research & Development, Avantor
10:30 - 11:0030 mins
Cell & Gene Therapy - Lehar 4
Design of a Central Workflow Platform for AAV-Manufacturing Process Development
- Jana Hersch - Scientific Consultant, Genedata
11:00 - 11:3030 mins
Cell & Gene Therapy - Lehar 4
Developing a Control Strategy for Full to Empty AAV Particles
- Franz Schnetzinger, Remote - VP QC and CMC Analytical Development, Gyroscope Therapeutics
11:30 - 12:0030 mins
Cell & Gene Therapy - Lehar 4
Purify small drug volumes better – GMP manufacturing of viral vectors
- Sushma Nayak Teichert - Global Product Manager, Cytiva
13:40 - 13:455 mins
Cell & Gene Therapy - Lehar 4
Chairperson's Remarks
- Volker Huppert - Chief Development Officer, Glycostem Therapeutics
13:45 - 14:1530 mins
Cell & Gene Therapy - Lehar 4
Controlling Manufacturing Processes in Pre-Commercial and Commercial Autologous Cell & Gene Therapy Products
- Amandine Breton - Associate Director of Cell Process MSAT, Orchard Therapeutics
14:15 - 14:4530 mins
Cell & Gene Therapy - Lehar 4
Platform Approaches for Process Understanding Across Different Biopharmaceutical Sectors: Varying Starting Raw Material in ATMP Processes
- Volker Huppert - Chief Development Officer, Glycostem Therapeutics
14:45 - 15:0015 mins
Cell & Gene Therapy - Lehar 4
Next-Generation Transfection Reagent for High Yield, Large Scale and Cost-Effective AAV Manufacturing
- Guillaume Freund - Scientific Support Manager, Polyplus-transfection
15:00 - 15:1515 mins
Cell & Gene Therapy - Lehar 4
HIP-Vax®: Solving the GMP Capacity Shortage for Viral Vector Production
- Angelique Lemckert - Technical Lead, Batavia Biosciences
Get the latest news.
As it happens
Sign up to get the latest on the agenda and speakers.
Filter
Streams
Clear
Choose Day